EXHIBIT 32








     In connection with the Quarterly Report of Tian'an Pharmaceutical Co., Ltd.
(the  "Company") on Form 10-QSB for the period ended June 30, 2007 as filed with
the  Securities  and Exchange  Commission  (the  "Report"),  Weng  Jianjun,  the
Principal  Executive Officer and Zhu Jie, the Principal Financial and Accounting
Officer of the  Company,  certify,  pursuant  to 18 U.S.C.  Section  1350,  as
adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that to the
best of their knowledge:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects the financial condition and results of the Company.


                                 TIAN'AN PHARMACEUTICAL CO., LTD.



August 9, 2007                    /s/ Weng Jianjun
                                  -------------------------------------
                                  Weng Jianjun, Principal Executive Officer


August 9, 2007                    /s/ Zhu Jie
                                  ------------------------------------
                                  Zhu Jie, Principal Financial and Accounting
                                  Officer